08840887 is referenced by 1 patents and cites 101 patents.

The present invention relates to the use of VEGF antagonists and a novel anti-α5β1 antibody for treating cancer and inhibiting angiogenesis and/or vascular permeability, including inhibiting abnormal angiogenesis in diseases. The present invention also relates to compositions and kits comprising novel anti-α5β1 antibodies and methods of making and using them.

Title
Antibodies
Application Number
13/112839
Publication Number
8840887 (B2)
Application Date
May 20, 2011
Publication Date
September 23, 2014
Inventor
Weilan Ye
Foster City
CA, US
Yan Wu
Foster City
CA, US
Gregory D Plowman
San Carlos
CA, US
Wei Ching Liang
Foster City
CA, US
Agent
Morrison & Foerster
Assignee
Genentech
CA, US
IPC
C07K 16/28
A61K 39/00
View Original Source